Characteristics & Business Summary
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays...
Income Statement Highlights
(¥ Million, except EPS/DPS in ¥)
| Fiscal Period | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | Forecast |
|---|---|---|---|---|---|---|---|
| Net Sales | 1,124 | 1,223 | 1,299 | 1,346 | 1,455 | 1,600 | — |
| Operating Profit | 39 | 191 | 211 | 220 | 250 | — | — |
| Ordinary Profit | 60 | 253 | 233 | 241 | 241 | 1,600 | — |
| Net Profit | 58 | 268 | 286 | 243 | 256 | 1 | — |
| EPS | ¥10 | ¥45 | ¥48 | ¥41 | ¥45 | ¥0 | — |
| DPS | ¥0 | ¥0 | ¥10 | ¥15 | ¥15 | — | — |
Balance Sheet & Valuation Highlights
Total Assets
—
Net Assets (Equity)
—
Equity Ratio
—
ROE (Return on Equity)
—
Cash & Equivalents
—
Interest-Bearing Debt
—
Capital Expenditure (CapEx)
—
Depreciation & Amort.
—